U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 45

1.
Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
A E Koopmans, J Vaarwater, D Paridaens, N C Naus, E Kilic, A de Klein, Rotterdam Ocular Melanoma Study group
Br J Cancer. 2013 Jul 23; 109(2): 493–496. Published online 2013 Jun 18. doi: 10.1038/bjc.2013.299
PMCID:
PMC3721402
AbstractArticlePDF–198K
2.
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma
Gülçin Gezgin, Sietse J. Luk, Jinfeng Cao, Mehmet Dogrusöz, Dirk M. van der Steen, Renate S. Hagedoorn, Daniëlle Krijgsman, Pieter A. van der Velden, Matthew G. Field, Gregorius P. M. Luyten, Karoly Szuhai, J. William Harbour, Ekaterina S. Jordanova, Mirjam H. M. Heemskerk, Martine J. Jager
JAMA Ophthalmol. Author manuscript; available in PMC 2017 Jul 13.
Published in final edited form as: JAMA Ophthalmol. 2017 Jun 1; 135(6): 541–549. doi: 10.1001/jamaophthalmol.2017.0729
PMCID:
PMC5509351
AbstractArticlePDF–574K
3.
Uveal melanoma: relatively rare but deadly cancer
S Kaliki, C L Shields
Eye (Lond) 2017 Feb; 31(2): 241–257. Published online 2016 Dec 2. doi: 10.1038/eye.2016.275
PMCID:
PMC5306463
AbstractArticlePDF–1.6M
4.
Metastatic disease from uveal melanoma: treatment options and future prospects
Richard D Carvajal, Gary K Schwartz, Tongalp Tezel, Brian Marr, Jasmine H Francis, Paul D Nathan
Br J Ophthalmol. 2017 Jan; 101(1): 38–44. Published online 2016 Aug 29. doi: 10.1136/bjophthalmol-2016-309034
PMCID:
PMC5256122
AbstractArticlePDF–876K
5.
The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma
Sarah E. Avedschmidt, Anna M. Stagner, Ralph C. Eagle, Jr., George J. Harocopos, Yali Dou, Rajesh C. Rao
Invest Ophthalmol Vis Sci. 2016 Nov; 57(14): 6242–6246. doi: 10.1167/iovs.16-20463
PMCID:
PMC5114033
AbstractArticlePDF–2.3M
6.
Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma
Scott D. Walter, Daniel L. Chao, William Feuer, Joyce Schiffman, Devron H. Char, J. William Harbour
JAMA Ophthalmol. Author manuscript; available in PMC 2016 Jul 29.
Published in final edited form as: JAMA Ophthalmol. 2016 Jul 1; 134(7): 734–740. doi: 10.1001/jamaophthalmol.2016.0913
PMCID:
PMC4966166
AbstractArticlePDF–232K
7.
Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes
Christina L. Decatur, Erin Ong, Nisha Garg, Hima Anbunathan, Anne M. Bowcock, Matthew G. Field, J. William Harbour
JAMA Ophthalmol. Author manuscript; available in PMC 2016 Jul 29.
Published in final edited form as: JAMA Ophthalmol. 2016 Jul 1; 134(7): 728–733. doi: 10.1001/jamaophthalmol.2016.0903
PMCID:
PMC4966162
AbstractArticlePDF–193K
8.
Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
Mark J. de Lange, Lubna Razzaq, Mieke Versluis, Sven Verlinde, Mehmet Dogrusöz, Stefan Böhringer, Marina Marinkovic, Gregorius P. M. Luyten, Rob J. W. de Keizer, Frank R. de Gruijl, Martine J. Jager, Pieter A. van der Velden
PLoS One. 2015; 10(9): e0138002. Published online 2015 Sep 14. doi: 10.1371/journal.pone.0138002
PMCID:
PMC4569098
AbstractArticlePDF–1.8M
9.
Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases
Elena Shagisultanova, Anna V. Gaponova, Rashid Gabbasov, Emmanuelle Nicolas, Erica A Golemis
Gene. Author manuscript; available in PMC 2016 Aug 1.
Published in final edited form as: Gene. 2015 Aug 1; 567(1): 1–11. Published online 2015 May 9. doi: 10.1016/j.gene.2015.04.086
PMCID:
PMC4458429
AbstractArticlePDF–961K
10.
MicroRNA Profiling in Intraocular Medulloepitheliomas
Deepak P. Edward, Hind Alkatan, Qundeel Rafiq, Charles Eberhart, Saleh Al Mesfer, Nicola Ghazi, Leen Al Safieh, Altaf A. Kondkar, Khaled K. Abu Amero
PLoS One. 2015; 10(3): e0121706. Published online 2015 Mar 25. doi: 10.1371/journal.pone.0121706
PMCID:
PMC4373864
AbstractArticlePDF–451K
11.
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
K G Griewank, R Murali, B Schilling, S Scholz, A Sucker, M Song, D Süsskind, F Grabellus, L Zimmer, U Hillen, K-P Steuhl, D Schadendorf, H Westekemper, M Zeschnigk
Br J Cancer. 2013 Jul 23; 109(2): 497–501. Published online 2013 Jun 25. doi: 10.1038/bjc.2013.312
PMCID:
PMC3721405
AbstractArticlePDF–324K
12.
Yield, Techniques, and Complications of Transvitreal and Transscleral Biopsies in Small Uveal Melanoma
Ryan Sangwoo Kim, Patricia Chevez-Barrios, Mukul Divatia, Maria Eugenia Bretana, Bin Teh, Amy Claire Schefler
JAMA Ophthalmol. 2018 May; 136(5): 482–488. Published online 2018 Mar 29. doi: 10.1001/jamaophthalmol.2018.0561
PMCID:
PMC5876837
AbstractArticle
13.
Differences in uveal melanomas between men and women from the British Isles
B E Damato, S E Coupland
Eye (Lond) 2012 Feb; 26(2): 292–299. Published online 2011 Nov 11. doi: 10.1038/eye.2011.272
PMCID:
PMC3272186
AbstractArticlePDF–283K
14.
Association between gene expression classification, proliferation and metastasis in uveal melanoma
Michael D. Onken, Lori A. Worley, J. William Harbour
Curr Eye Res. Author manuscript; available in PMC 2011 Dec 5.
Published in final edited form as: Curr Eye Res. 2010 Sep; 35(9): 857–863. doi: 10.3109/02713683.2010.493265
PMCID:
PMC3230327
AbstractArticlePDF–378K
15.
Ophthalmic Manifestations and Histopathology of Xeroderma Pigmentosum: Two Clinicopathological Cases and a Review of the Literature
Hema L. Ramkumar, Brian P. Brooks, Xiaoguang Cao, Deborah Tamura, John J. DiGiovanna, Kenneth H. Kraemer, Chi-Chao Chan
Surv Ophthalmol. Author manuscript; available in PMC 2012 Jul 1.
Published in final edited form as: Surv Ophthalmol. 2011 Jul-Aug; 56(4): 348–361. doi: 10.1016/j.survophthal.2011.03.001
PMCID:
PMC3137889
AbstractArticlePDF–6.8M
16.
Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma
Abhirami Radhakrishnan, Nirmala Badhrinarayanan, Jyotirmay Biswas, Subramanian Krishnakumar
Mol Vis. 2009; 15: 2146–2154. Published online 2009 Oct 22.
PMCID:
PMC2773734
AbstractArticlePDF–5.0M
17.
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
J Bauer, E Kilic, J Vaarwater, B C Bastian, C Garbe, A de Klein
Br J Cancer. 2009 Sep 1; 101(5): 813–815. Published online 2009 Aug 4. doi: 10.1038/sj.bjc.6605226
PMCID:
PMC2736834
AbstractArticlePDF–140K
18.
The T1799A point mutation is present in posterior uveal melanoma
C S Janssen, R Sibbett, F L Henriquez, I C McKay, E G Kemp, F Roberts
Br J Cancer. 2008 Nov 4; 99(10): 1673–1677. Published online 2008 Nov 4. doi: 10.1038/sj.bjc.6604731
PMCID:
PMC2584949
AbstractArticlePDF–144K
19.
Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma
K Sisley, M A Parsons, J Garnham, A M Potter, D Curtis, R C Rees, I G Rennie
Br J Cancer. 2000 Jan; 82(2): 330–338. Published online 2000 Jan 18. doi: 10.1054/bjoc.1999.0923
PMCID:
PMC2363277
SummaryPDF–165K
20.
Expression of the rasT24 oncogene in the ciliary body pigment epithelium and retinal pigment epithelium results in hyperplasia, adenoma, and adenocarcinoma.
P. Chévez-Barrios, D. L. Schaffner, R. Barrios, P. A. Overbeek, R. M. Lebovitz, M. W. Lieberman
Am J Pathol. 1993 Jul; 143(1): 20–28.
PMCID:
PMC1886968
SummaryPage BrowsePDF–2.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center